Abstract
Parkinson’s disease is a neurodegenerative disease affecting people worldwide. Since the reasons for Parkinson’s disease are still unknown and currently there is no cure for the disease, the management of the disease is directed towards handling of the underlying symptoms with antiparkinson medications. In this paper, we present a method for visualization of the patients’ overall status and their antiparkinson medications therapy. The purpose of the proposed visualization method is multi-fold: understanding the clinicians’ decisions for therapy modifications, identification of the underlying guidelines for management of Parkinson’s disease, as well as identifying treatment differences between groups of patients. The resulting patterns of disease progression show that there are differences between male and female patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The visualization method is closely related to the PPMI data and the cluster label results from [22]. As the permission to use the PPMI data can be obtained only from www.ppmi-info.org/data, we cannot share the complete solution but the code is available upon request to the first author of the paper.
- 2.
A skip gram, e.g., a d-skip-n-gram, is a sequence of n items (disease progression phases, in our case), which are not necessarily consecutive, but gaps of up to d intermediate items are tolerated. The advantage of skip-grams over ordinary n-grams is that they are more noise tolerant and offer stronger statistical support for possibly interrupted sequence patterns.
References
Blockeel, H., Raedt, L.D., Ramon, J.: Top-down induction of clustering trees. In: Proceedings of the 15th International Conference on Machine Learning, ICML 1998. pp. 55–63 (1998)
Dalrymple-Alford, J., et al.: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75(19), 1717–1725 (2010)
Ferreira, J., et al.: Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson’s disease. Eur. J. Neurol. 20(1), 5–15 (2013)
Fox, S.H., et al.: The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson’s disease. Mov. Disord. 26(S3), S2–S41 (2011)
Goetz, C., Luo, S., Wang, L., Tilley, B., LaPelle, N., Stebbins, G.: Handling missing values in the MDS-UPDRS. Mov. Disord. 30(12), 1632–1638 (2015)
Goetz, C., et al.: Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23(15), 2129–2170 (2008)
Guthrie, D., Allison, B., Liu, W., Guthrie, L., Wilks, Y.: A closer look at skip-gram modelling. In: Proceedings of the 5th International Conference on Language Resources and Evaluation, LREC 2006. pp. 1–4 (2006)
Kosara, R., Miksch, S.: Visualization methods for data analysis and planning in medical applications. Int. J. Med. Inform. 68(1), 141–153 (2002)
Marek, K., et al.: The Parkinson’s progression markers initiative (PPMI). Prog. Neurobiol. 95(4), 629–635 (2011)
National Collaborating Centre for Chronic Conditions: Parkinson’s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. Royal College of Physicians, London (2006)
Olanow, W., Watts, R., Koller, W.: An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology 56(suppl 5), S1–S88 (2001)
Plaisant, C., Milash, B., Rose, A., Widoff, S., Shneiderman, B.: Lifelines: visualizing personal histories. In: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, pp. 221–227. CHI 1996, ACM, New York, NY, USA (1996)
Seppi, K., et al.: The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov. Disord. 26(S3) (2011)
Struyf, J., Ženko, B., Blockeel, H., Vens, C., Džeroski, S.: CLUS: User’s Manual (2010)
Tsanas, A.: Accurate telemonitoring of Parkinsons disease symptom severity using nonlinear speech signal processing and statistical machine learning. Ph.D. thesis, Oxford University, UK (2012)
Tsanas, A., Little, M., McSharry, P., Ramig, L.: Accurate telemonitoring of Parkinson’s disease progression by noninvasive speech tests. IEEE Trans. Biomed. Eng. 57(4), 884–893 (2010)
Tsanas, A., Little, M.A., McSharry, P.E., Ramig, L.O.: Accurate telemonitoring of Parkinson’s disease progression by noninvasive speech tests. IEEE Trans. Biomed. Eng. 57(4), 884–893 (2010)
Tsanas, A., Little, M.A., McSharry, P.E., Ramig, L.O.: Enhanced classical Dysphonia measures and sparse regression for telemonitoring of Parkinson’s disease progression. In: Proceedings of the IEEE International Conference on Acoustics Speech and Signal Processing, ICASSP 2010, pp. 594–597. IEEE (2010)
Tsanas, A., Little, M.A., McSharry, P.E., Spielman, J., Ramig, L.O.: Novel speech signal processing algorithms for high-accuracy classification of Parkinson’s disease. IEEE Trans. Biomed. Eng. 59(5), 1264–1271 (2012)
Tufte, E.R.: The Visual Display of Quantitative Information. Graphics Press, Cheshire, CT, USA (2001)
Valmarska, A., Miljkovic, D., Konitsiotis, S., Gatsios, D., Lavrač, N., Robnik-Šikonja, M.: Symptoms and medications change patterns for Parkinson’s disease patients stratification. Artif. Intell. Med. (2018). https://doi.org/10.1016/j.artmed.2018.04.010
Valmarska, A., Miljkovic, D., Lavrač, N., Robnik-Šikonja, M.: Analysis of medications change in Parkinson’s disease progression data. J. Intell. Inf. Syst. 51(2), 301–337 (2018)
Valmarska, A., Miljkovic, D., Robnik-Šikonja, M., Lavrač, N.: Multi-view approach to Parkinson’s disease quality of life data analysis. In: Proceedings of the International Workshop on New Frontiers in Mining Complex Patterns, pp. 163–178. Springer (2016)
Visser, M., Marinus, J., Stiggelbout, A.M., Van Hilten, J.J.: Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov. Disord. 19(11), 1306–1312 (2004)
Washburn, R.A., Smith, K.W., Jette, A.M., Janney, C.A.: The physical activity scale for the elderly (PASE): development and evaluation. J. Clin. Epidemiol. 46(2), 153–162 (1993)
Acknowledgments
This work was supported by the PD_manager project, funded within the EU Framework Programme for Research and Innovation Horizon 2020 grant 643706. We acknowledge also the support of the Slovenian Research Agency (research core funding program P2-0103 and project P2-0209).
Data used in the preparation of this article were obtained from the Parkinsons Progression Markers Initiative (PPMI) (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org. PPMI—a public-private partnership—is funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners. Corporate Funding Partners: AbbVie, Avid Radiopharmaceuticals, Biogen, BioLegend, Bristol-Myers Squibb, GE Healthcare, GLAXOSMITHKLINE (GSK), Eli Lilly and Company, Lundbeck, Merck, Meso Scale Discovery (MSD), Pfizer Inc, Piramal Imaging, Roche, Sanofi Genzyme, Servier, Takeda, Teva, UCB. Philanthropic Funding Partners: Golub Capital. List of funding partners can be also found at www.ppmi-info.org/fundingpartners.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this paper
Cite this paper
Valmarska, A., Miljkovic, D., Robnik–Šikonja, M., Lavrač, N. (2018). Visualization and Analysis of Parkinson’s Disease Status and Therapy Patterns. In: Soldatova, L., Vanschoren, J., Papadopoulos, G., Ceci, M. (eds) Discovery Science. DS 2018. Lecture Notes in Computer Science(), vol 11198. Springer, Cham. https://doi.org/10.1007/978-3-030-01771-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-030-01771-2_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01770-5
Online ISBN: 978-3-030-01771-2
eBook Packages: Computer ScienceComputer Science (R0)